Preclinical testing involves evaluating the drug's safety profile in animal models. This stage assesses acute, subchronic, and chronic toxicity, alongside specific studies on genotoxicity, carcinogenicity, and reproductive toxicity. The goal is to identify any potential adverse effects before the drug is tested in humans.
